| 000 | 01578 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516194329.0 | ||
| 264 | 0 | _c20150917 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1369-1635 | ||
| 024 | 7 |
_a10.3109/09537104.2013.877581 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKomosa, A | |
| 245 | 0 | 0 |
_aComparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-Egitromb. _h[electronic resource] |
| 260 |
_bPlatelets _c2015 |
||
| 300 |
_a43-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPercutaneous Coronary Intervention |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSiller-Matula, J M | |
| 700 | 1 | _aKowal, J | |
| 700 | 1 | _aLesiak, M | |
| 700 | 1 | _aSiniawski, A | |
| 700 | 1 | _aMączyński, M | |
| 700 | 1 | _aMichalak, M | |
| 700 | 1 | _aMularek-Kubzdela, T | |
| 700 | 1 | _aGrajek, S | |
| 773 | 0 |
_tPlatelets _gvol. 26 _gno. 1 _gp. 43-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/09537104.2013.877581 _zAvailable from publisher's website |
| 999 |
_c23518764 _d23518764 |
||